OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System

Core Insights - OrthoPediatrics Corp. has launched the VerteGlide Spinal Growth Guidance System in the U.S. to treat Early Onset Scoliosis, marking the company's 80th system designed for pediatric musculoskeletal issues [1][4] Product Overview - The VerteGlide system is a guided growth technology aimed at children under 10 suffering from Early Onset Scoliosis, a condition that can lead to severe pulmonary and digestive dysfunction [2] - This system is designed to correct deformities and reduce the need for repeat surgeries until the child reaches skeletal maturity [2] - The device has received FDA clearance and is set for a limited launch with initial surgeries planned for summer 2025 [2] Development and Collaboration - Dr. Richard McCarthy and Dr. Scott Luhmann have played key roles in the design and development of the VerteGlide system [3] - The launch of VerteGlide reflects the company's commitment to addressing the needs of children with scoliosis, as stated by the President of the Scoliosis division, Greg Odle [3] - The system utilizes Shilla™ technology licensed from Medtronic, showcasing collaboration in advancing pediatric orthopedic solutions [3] Company Background - Founded in 2006, OrthoPediatrics focuses exclusively on pediatric orthopedics, offering a comprehensive range of products to improve the lives of children with orthopedic conditions [4] - The company markets 80 products across major categories including trauma and deformity, scoliosis, and sports medicine, distributing in the U.S. and over 70 countries [4]